The Board of BBI Life Sciences Corporation recommended the payment of a final dividend of HKD 0.014 per share for the year ended 31 December 2017, amounting to a total sum of approximately HKD 7,637,226.70 (equivalent to RMB 6,127,300) to Shareholders out of share premium account of the company. The final dividend is subject to the approval by the Shareholders at the forthcoming annual general meeting of the company to be held on 29 June 2018. The final dividend, if approved, is expected to be paid on 31 July 2018 to the Shareholders whose names appear on the register of members of the company on 6 July 2018.